Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 16, Pages 4199
Publisher
MDPI AG
Online
2021-08-23
DOI
10.3390/cancers13164199
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
- (2020) Dan Liao et al. NATURE CELL BIOLOGY
- Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid
- (2020) Mariah M. Hoffman et al. Cancers
- Apoptotic Effects of N-(2-hydroxyphenyl)-2-propylpentanamide on U87-MG and U-2 OS Cells and Antiangiogenic Properties
- (2020) Paola Castillo-Juárez et al. Anti-Cancer Agents in Medicinal Chemistry
- PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma
- (2020) Branden A. Smeester et al. BONE
- Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma
- (2020) Jeremy J. McGuire et al. INTERNATIONAL JOURNAL OF CANCER
- Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway
- (2020) Ashley VanCleave et al. Oncotarget
- The HDAC Inhibitor Domatinostat Promotes Cell Cycle Arrest, Induces Apoptosis and Increases Immunogenicity of Merkel Cell Carcinoma Cells
- (2020) Lina Song et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor
- (2020) Rui Han et al. Molecular Therapy-Oncolytics
- Tegavivint and the β-catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma
- (2019) Motonari Nomura et al. JNCI-Journal of the National Cancer Institute
- Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells
- (2019) Marion Wobser et al. Journal of Hematology & Oncology
- Podocyte histone deacetylase activity regulates murine and human glomerular diseases
- (2019) Kazunori Inoue et al. JOURNAL OF CLINICAL INVESTIGATION
- HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells
- (2019) Jing Li et al. CELL BIOLOGY AND TOXICOLOGY
- Metformin and 4SC‐202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma
- (2019) Yuan He et al. Cancer Medicine
- Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group
- (2019) Ryan D. Roberts et al. CANCER
- Osteosarcoma in the Post Genome Era: Preclinical Models and Approaches to Identify Tractable Therapeutic Targets
- (2019) Wilson Castillo-Tandazo et al. Current Osteoporosis Reports
- Class I HDAC inhibitors enhance YB ‐1 acetylation and oxidative stress to block sarcoma metastasis
- (2019) Amal M El‐Naggar et al. EMBO REPORTS
- Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
- (2019) Jo Lynne Rokita et al. Cell Reports
- Trichostatin A activates FOXO1 and induces autophagy in osteosarcoma
- (2018) Yunjuan Bai et al. Archives of Medical Science
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
- (2018) James J Morrow et al. NATURE MEDICINE
- Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma
- (2018) K. Patatsos et al. Veterinary and Comparative Oncology
- Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
- (2018) Jay H. Kalin et al. Nature Communications
- Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates
- (2018) Shengdong Wang et al. Frontiers in Immunology
- Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
- (2018) Xiaotu Ma et al. NATURE
- Synergistic antitumor effect of suberoylanilide hydroxamic acid and cisplatin in osteosarcoma cells
- (2018) Mengyi Hou et al. Oncology Letters
- Genome-Informed Targeted Therapy for Osteosarcoma
- (2018) Leanne C Sayles et al. Cancer Discovery
- Panobinostat mediated cell death. A novel therapeutic approach for osteosarcoma
- (2018) André Wirries et al. Oncotarget
- Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies
- (2018) Bastian von Tresckow et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy
- (2018) Marcella La Noce et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting the Wnt/β-catenin pathway in human osteosarcoma cells
- (2018) Fang Fang et al. Oncotarget
- Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations
- (2018) Amos H.P. Loh et al. CANCER LETTERS
- Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance
- (2017) Wolfgang Gruber et al. INTERNATIONAL JOURNAL OF CANCER
- The Effect of VPA on Increasing Radiosensitivity in Osteosarcoma Cells and Primary-Culture Cells from Chemical Carcinogen-Induced Breast Cancer in Rats
- (2017) Guochao Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications
- (2017) Parunya Chaiyawat et al. MODERN PATHOLOGY
- Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner
- (2017) Vivek Kumar Mishra et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1
- (2017) Shi Ying et al. ONCOLOGY RESEARCH
- Epigenetic plasticity and the hallmarks of cancer
- (2017) William A. Flavahan et al. SCIENCE
- Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
- (2017) Chao Zhang et al. Oncotarget
- Whole-exome analysis in osteosarcoma to identify a personalized therapy
- (2017) Caterina Chiappetta et al. Oncotarget
- Down-regulation of HDAC3 inhibits growth of cholangiocarcinoma by inducing apoptosis
- (2017) Mingming Zhang et al. Oncotarget
- Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis
- (2017) Simin Kiany et al. OncoImmunology
- 4SC-202 activates ASK1-dependent mitochondrial apoptosis pathway to inhibit hepatocellular carcinoma cells
- (2016) Meili Fu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Histone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation
- (2016) Zhantao Deng et al. International Journal of Biological Sciences
- The molecular hallmarks of epigenetic control
- (2016) C. David Allis et al. NATURE REVIEWS GENETICS
- The burden of musculoskeletal diseases in the United States
- (2016) Edward Yelin et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines
- (2016) Maria Pinkerneil et al. Targeted Oncology
- Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells
- (2016) Huang Zhijun et al. TUMOR BIOLOGY
- Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2–p53 signaling
- (2016) Chuhai Xie et al. OncoTargets and Therapy
- Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression
- (2016) Heng Zeng et al. Oncotarget
- Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
- (2016) Ivan Kopljar et al. Stem Cells Translational Medicine
- Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells
- (2015) KOJI YAMANEGI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Aberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma
- (2015) Milcah C. Scott et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor Cells
- (2015) Meghan E McGee-Lawrence et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Novel Histone Deacetylase Inhibitors Induce Growth Arrest, Apoptosis, and Differentiation in Sarcoma Cancer Stem Cells
- (2015) Gemma Di Pompo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling
- (2015) Jessica M Foley et al. Journal of Translational Medicine
- Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma
- (2015) Diana Yu et al. Scientific Reports
- The HDAC Inhibitor Vorinostat Diminishes theIn VitroMetastatic Behavior of Osteosarcoma Cells
- (2015) Xiaodong Mu et al. Biomed Research International
- Notch Activation as a Driver of Osteogenic Sarcoma
- (2014) Jianning Tao et al. CANCER CELL
- Wnt5a promotes migration of human osteosarcoma cells by triggering a phosphatidylinositol-3 kinase/Akt signals
- (2014) Ailiang Zhang et al. Cancer Cell International
- Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma
- (2014) C. Khanna et al. CLINICAL CANCER RESEARCH
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line
- (2014) Enrico Capobianco et al. PLoS One
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- Tubulin polymerization promoting protein 1 (TPPP1) increases β-catenin expression through inhibition of HDAC6 activity in U2OS osteosarcoma cells
- (2013) Alice V. Schofield et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts
- (2013) Richard D.W. Kelly et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- FOXO Transcription Factors Control E2F1 Transcriptional Specificity and Apoptotic Function
- (2013) I. Shats et al. CANCER RESEARCH
- Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program
- (2013) Hernan Carol et al. PEDIATRIC BLOOD & CANCER
- Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage
- (2013) T Ozaki et al. Cell Death & Disease
- Antitumor Activity of Histone Deacetylase Inhibitor Trichostatin A in Osteosarcoma Cells
- (2012) Dong-Dong Cheng et al. Asian Pacific Journal of Cancer Prevention
- Histone deacetylase 3 is required for maintenance of bone mass during aging
- (2012) Meghan E. McGee-Lawrence et al. BONE
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Hdac-Mediated Control of Endochondral and Intramembranous Ossification
- (2012) Jennifer J. Westendorf et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)
- (2012) Jodi A. Muscal et al. PEDIATRIC BLOOD & CANCER
- Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation
- (2012) C. Blattmann et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases
- (2011) Nadezhda V. Koshkina et al. CANCER
- One NOTCH Further: Jagged 1 in Bone Metastasis
- (2011) Jianning Tao et al. CANCER CELL
- Upregulation of Polo-like kinase 2 gene expression by GATA-1 acetylation in human osteosarcoma MG-63 cells
- (2011) Tao Shen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Dissection of Wnt5a-Ror2 Signaling Leading to Matrix Metalloproteinase (MMP-13) Expression
- (2011) Kaoru Yamagata et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma
- (2011) Luke A. Wittenburg et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Acetylation controls Notch3 stability and function in T-cell leukemia
- (2011) R Palermo et al. ONCOGENE
- Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells
- (2010) Cao Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Histone deacetylases in skeletal development and bone mass maintenance
- (2010) Meghan E. McGee-Lawrence et al. GENE
- Enhancement of Radiation Response in Osteosarcoma and Rhabomyosarcoma Cell Lines by Histone Deacetylase Inhibition
- (2010) Claudia Blattmann et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Development and characterization of a conditionally immortalized human fetal osteoblastic cell line
- (2010) Steven A. Harris et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice
- (2010) Sam D. Molyneux et al. JOURNAL OF CLINICAL INVESTIGATION
- Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity
- (2010) Yamanegi ONCOLOGY REPORTS
- Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model
- (2010) Jason T. Yustein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene ontology analysis for RNA-seq: accounting for selection bias
- (2010) Matthew D Young et al. GENOME BIOLOGY
- Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation
- (2009) M Tanaka et al. BRITISH JOURNAL OF CANCER
- Notch signaling contributes to the pathogenesis of human osteosarcomas
- (2009) F. Engin et al. HUMAN MOLECULAR GENETICS
- Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
- (2009) Maya Kansara et al. JOURNAL OF CLINICAL INVESTIGATION
- Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling
- (2009) M Enomoto et al. ONCOGENE
- Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program
- (2009) Nino Keshelava et al. PEDIATRIC BLOOD & CANCER
- Sodium valproate, a histone deacetylase inhibitor, decreases the secretion of soluble Fas by human osteosarcoma cells and increases their sensitivity to Fas-mediated cell death
- (2008) Koji Yamanegi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Involvement of Extracellular Signal-Regulated Kinase Activation in Human Osteosarcoma Cell Resistance to the Histone Deacetylase Inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone]
- (2008) H. Matsubara et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now